NORA MARGOLIS: Open Payments
NPI 1629134408 · NORRISTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,115 in 49 payments from 7 companies in 2025. Trend: 2023 $1,255 · 2024 $1,170 · 2025 $1,115
Food & beverage: $1,115
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 14 | $341 |
| ABBVIE INC. | 16 | $331 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $189 |
| Otsuka America Pharmaceutical, Inc. | 5 | $96 |
| Neurocrine BioSciences, Inc. | 3 | $79 |
| E.R. Squibb & Sons, L.L.C. | 3 | $61 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
Products named: Qelbree, VRAYLAR, CAPLYTA, REXULTI, INGREZZA, COBENFY, FANAPT.
Industry payments across PA — which companies pay providers there.
